Comparison of pretherapeutic osseous tumor volume and standard hematology for prediction of hematotoxicity after PSMA-targeted radioligand therapy.

Liam WidjajaRudolf A WernerTobias L RossFrank M BengelThorsten Derlin

Published in: European journal of nuclear medicine and molecular imaging (2021)

Pretherapeutic leukocyte, lymphocyte, and platelet levels themselves are strong predictors for early and late hematotoxicity under PSMA-directed RLT, and are better suited than PET-based osseous TV for this purpose.

Keyphrases

pet ct
pet imaging
peripheral blood
positron emission tomography
cancer therapy
computed tomography
mesenchymal stem cells
clinical evaluation